Abstract
Commentary: The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.
Highlights
Pulmonary arterial hypertension (PAH) is a progressive and irreversible lung disease that reduces survival
PAH is categorized as a pulmonary artery pressure greater than 25 mmHg, with various factors contributing to the pathogenesis of the disease, including higher levels of endothelin-1, decreased nitric oxide (NO) synthase expression, and inhibition of the prostacyclin pathway which leads to decreased relaxation and induced proliferation of pulmonary artery smooth muscle cells (PASMCs) (McLaughlin and McGoon, 2006)
The results show that expression levels of sphingosine kinase 1 (SphK1) and S1P were considerably higher in the lungs of patients with PAH and in PH rodent models after exposure to hypoxia (10% O2) for 4 weeks, compared to normoxic control animals
Summary
Pulmonary arterial hypertension (PAH) is a progressive and irreversible lung disease that reduces survival. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension by Chen, J., Tang, H., Sysol, J. PAH is categorized as a pulmonary artery pressure greater than 25 mmHg, with various factors contributing to the pathogenesis of the disease, including higher levels of endothelin-1, decreased nitric oxide (NO) synthase expression, and inhibition of the prostacyclin pathway which leads to decreased relaxation and induced proliferation of pulmonary artery smooth muscle cells (PASMCs) (McLaughlin and McGoon, 2006).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.